Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis
Makaleler > Tam Makale · 2003
Yazarlar: İLHAN BİÇER, Kenan AKSU, Zuhal PARILDAR, TİJEN TANYALÇIN, EKER DOĞANAVŞARGİL, FATMA KUTAY
RHEUMATOLOGY INTERNATIONAL, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2003, cilt 23, ss 221-225
DOI: 10.1007/s00296-003-0294-3
Özet
Urinary glycosaminoglycans (GAG) and heparan sulfate (HS) are considered to be markers of early renal involvement. This study was undertaken to demonstrate their excretion patterns in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) with and without arthritis. Serum creatinine and urinary GAG, HS, microalbumin, and creatinine measurements were made in 51 biopsy-proven lupus nephritis (LN) cases, 12 RA patients, and 21 healthy controls. Urinary GAG and HS levels were higher in the LN and RA groups than in controls. Heparan sulfate excretions and SLE disease activity index (SLEDAI) scores were no different between SLE patients with classes 1 and 2 (group A) and those with classes 3, 4, and 5 (group B) renal involvement. However, GAG and microalbumin excretions were significantly high in the latter. There were no differences in GAG and HS excretions between normoalbuminuric, microalbuminuric, and macroproteinuric SLE patients or between those with and without arthritis. In conclusion, urinary GAG and HS, being unrelated to the presence of arthritis, are independent markers of LN. Extrarenal causes or subclinical renal involvement may be responsible in RA due to their increased excretion in these patients.